Literature DB >> 5306142

Raised IgG antiglobulin factors in Still's disease.

G Torrigiani, B M Ansell, E E Chown, I M Roitt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5306142      PMCID: PMC1010511          DOI: 10.1136/ard.28.4.424

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  5 in total

1.  Prognosis in Still's disease.

Authors:  B M ANSELL; E G BYWATERS
Journal:  Bull Rheum Dis       Date:  1959-05

2.  The hydrolysis of rabbit y-globulin and antibodies with crystalline papain.

Authors:  R R PORTER
Journal:  Biochem J       Date:  1959-09       Impact factor: 3.857

3.  Differential Agglutination Titre (D.A.T.) in Juvenile Rheumatoid Arthritis.

Authors:  E G Bywaters; M E Carter; F E Scott
Journal:  Ann Rheum Dis       Date:  1959-09       Impact factor: 19.103

4.  Antiglobulin factors in sera from patients with rheumatoid arthritis and normal subjects. Quantitative estimation in different immunoglobulin classes.

Authors:  G Torrigiani; I M Roitt
Journal:  Ann Rheum Dis       Date:  1967-07       Impact factor: 19.103

5.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09
  5 in total
  22 in total

1.  Hidden' IgG antiglobulins in normal human serum.

Authors:  F C Hay; L J Nineham; G Torrigiani; I M Roitt
Journal:  Clin Exp Immunol       Date:  1976-08       Impact factor: 4.330

2.  Serum antigammaglobulins in juvenile rheumatoid arthritis.

Authors:  R Bardfeld; V Sobeslavská; C Sobeslavský
Journal:  Ann Rheum Dis       Date:  1971-01       Impact factor: 19.103

3.  IgG anti-IgG antibodies in rheumatoid arthritis and certain other conditions.

Authors:  J L Abruzzo; R Heimer
Journal:  Ann Rheum Dis       Date:  1974-05       Impact factor: 19.103

4.  Hidden rheumatoid factor in seronegative juvenile rheumatoid arthritis.

Authors:  T Moore; R W Dorner; J Zuckner
Journal:  Ann Rheum Dis       Date:  1974-05       Impact factor: 19.103

5.  Complement metabolism in the seronegative arthritides.

Authors:  K Whaley; B Canesi; A Moseley; W Morrow; R Sturrock; W Mitchell; W C Dick
Journal:  Ann Rheum Dis       Date:  1974-11       Impact factor: 19.103

6.  Inhibition of human mixed lymphocyte reaction by antibodies to immunoglobulin light chain determinants.

Authors:  M F Greaves; G Torrigiani; I M Roitt
Journal:  Clin Exp Immunol       Date:  1971-09       Impact factor: 4.330

7.  Impaired delayed hypersensitivity in juvenile rheumatoid arthritis.

Authors:  H M Höyeraal
Journal:  Ann Rheum Dis       Date:  1973-07       Impact factor: 19.103

8.  Procainamide-induced systemic lupus erythematosus.

Authors:  P J Sheldon; W R Williams
Journal:  Ann Rheum Dis       Date:  1970-05       Impact factor: 19.103

9.  Measurement of rheumatoid factors by an enzyme-linked immunosorbent assay (ELISA) and comparison with other methods.

Authors:  J L Bampton; T E Cawston; M V Kyle; B L Hazleman
Journal:  Ann Rheum Dis       Date:  1985-01       Impact factor: 19.103

10.  Antiglobulins in Nigerians with rheumatoid disease.

Authors:  G O Okafor; M W Turner; B M Greenwood
Journal:  Ann Rheum Dis       Date:  1975-04       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.